Human Immunodeficiency Virus Type 1 Infection, Mucosal Immunity, and Pathogenesis and Extramural

Kresina, Thomas F.; Mathieson, Bonnie
May 1999
Journal of Infectious Diseases;5/15/99 Supplement 3, Vol. 179, pS392
Academic Journal
Discusses the interactions of HIV with M cells and other cells of the mucosa in infection and as part of the pathogenesis of HIV infection. Transmission of HIV via mucosal surfaces; Generation of protective immunity; Role of the gastrointestinal tract in HIV infection; Overview of research conducted by the United States National Institutes of Health.


Related Articles

  • Gut microbes out of control in HIV infection. Haynes, Barton F. // Nature Medicine;Dec2006, Vol. 12 Issue 12, p1351 

    The article provides evidence that a cause of immune activation in chronic HIV infection may be breakdown of the gut mucosal barrier and stimulation of immune cells by microbial products. This process is called microbial translocation. Microbial translocation occurs following damage to the...

  • Innate Molecular and Anatomic Mucosal Barriers against HIV Infection in the Genital Tract of HIV-Exposed Seronegative Individuals. Broliden, Kristina // Journal of Infectious Diseases;11/1/2010 Supplement, Vol. 202, pS351 

    Sexual transmission is the single most common mechanism for acquiring infection with human immunodeficiency virus (HIV), and the efficiency of transmission reflects the biology of the mucosal site. The localization and phenotypic characterization of HIV target cells and receptors and the...

  • Human Immunodeficiency Virus Pathogenesis and Prospects for Immune Control in Patients with Established Infection. Mayer, Kenneth H.; Cohen, Daniel E.; Walker, Bruce D. // Clinical Infectious Diseases;6/15/2001, Vol. 32 Issue 12, p1756 

    Focuses on the clinical implications of advances in understanding HIV-1 pathogenesis, with particular emphasis on the role of immune responses in controlling viremia. Natural history of acute HIV infection; Clinical manifestations of acute HIV-1 infection; Viral and host factors that influence...

  • Primary and Chronic HIV Infection Differently Modulates Mucosal Vδ1 and Vδ2 T-Cells Differentiation Profile and Effector Functions. Cimini, Eleonora; Agrati, Chiara; D’Offizi, Gianpiero; Vlassi, Chrysoula; Casetti, Rita; Sacchi, Alessandra; Lionetti, Raffaella; Bordoni, Veronica; Tumino, Nicola; Scognamiglio, Paola; Martini, Federico // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Gut-associated immune system has been identified as a major battlefield during the early phases of HIV infection. γδ T-cells, deeply affected in number and function after HIV infection, are able to act as a first line of defence against invading pathogens by producing antiviral soluble...

  • Mucosal gatekeepers: Selecting HIV viruses for early infection. Bomsel, Morgane; David, Violaine // Nature Medicine;Feb2002, Vol. 8 Issue 2, p114 

    Focuses on a study that shows that mucosal cells are the principal portal of HIV-1 entry. Description of a new model system by researchers Smith and colleagues to study the initial events of HIV-1 entry in monostratified epithelium; Occurrence of a selection process at the site of the HIV-1 entry.

  • Transmission of HIV possibly associated with exposure of mucous membrane to contaminated blood.  // JAMA: Journal of the American Medical Association;08/20/97, Vol. 278 Issue 7, p539 

    Summarizes an investigation into the case of a woman who may have become infected with the human immunodeficiency virus (HIV) through exposure of a mucous membrane to contaminated blood. Sexual activity of woman with HIV infected partner; Dental problems of both; Onset of symptoms in woman;...

  • Innate Immunity and HIV-1 Infection. Lehner, T.; Wang, Y.; Whittall, T.; Seidl, T. // Advances in Dental Research;Apr2011, Vol. 23 Issue 1, p19 

    HIV-1 is predominantly transmitted through mucosal tissues, targeting CD4+CCR5+ T cells, 50% of which are destroyed within 2 weeks of infection. Conventional vaccination strategies have so far failed to prevent HIV-1 infection. Neither antibodies nor cytotoxic lymphocytes are capable of mounting...

  • Transmission, acute HIV-1 infection and the quest for strategies to prevent infection. Pope, Melissa; Haase, Ashley T // Nature Medicine;Jul2003, Vol. 9 Issue 7, p847 

    By the acute stage of HIV-1 infection, the immune system already faces daunting challenges. Research on mucosal barriers and the events immediately after heterosexual transmission that precede this acute stage could facilitate the development of effective microbicides and vaccines.

  • Fatal Immune Restoration Disease in Human Immunodeficiency Virus Type 1--Infected Patients with Progressive Multifocal Leukoencephalopathy: Impact of Antiretroviral Therapy--Associated Immune Reconstitution. Safdar, Amar; Rubocki, Ronald J.; Horvath, Joseph A.; Narayan, Kailash K.; Waldron, Robert L. // Clinical Infectious Diseases;11/15/2002, Vol. 35 Issue 10, p1250 

    Immune reconstitution resulting from use of highly active antiretroviral therapy in patients infected with human immunodeficiency virus type 1 (HIV-1) has been associated with a significant decrease in infectious morbidity and with improved survival. Occasionally, patients with quiescent disease...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics